Primary thrombosis prevention in aPL-positive patients

被引：0
|
作者：
Kathleen M. O’Neil
机构：
来源：
Current Rheumatology Reports | 2008年 / 10卷 / 1期
关键词：
Aspirin; Thrombotic Event; Anticardiolipin Antibody; Thrombotic Disease; International Consensus Statement;
D O I：
10.1007/s11926-008-0010-0
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：59 / 61
页数：2
相关论文
共 50 条
  • [1] APLASA - A randomized, double-blind, placebo-controlled primary thrombosis prevention trial in asymptomatic aPL-positive individuals with aspirin
    Erkan, D.
    Harrison, M. J.
    Levy, R.
    Peterson, M.
    Petri, M.
    Sammaritano, L.
    Unalp-Arida, A.
    Vilela, V.
    Yazici, Y.
    Lockshin, M. D.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2007, 25 (02) : 135 - 135
  • [2] Real world experience with aPL: Comparison between APS and asymptomatic aPL-positive patients
    Derksen, W
    Erkan, D
    Kaplan, V
    Sammaritano, L
    Lockshin, MD
    THROMBOSIS RESEARCH, 2004, 114 (5-6) : 635 - 636
  • [3] Does warfarin prevent venous thromboembolic events in aPL-positive patients?
    Mazzone, Michael F.
    Jamieson, Barbara
    JOURNAL OF FAMILY PRACTICE, 2007, 56 (04): : 309 - 311
  • [4] Aplasa study update: Primary thrombosis prevention in asymptomatic aPL(+) patients with aspirin (ASA)
    Erkan, D
    Sammaritano, L
    Levy, R
    Harrison, MJ
    Peterson, M
    Yazici, Y
    Lockshin, MD
    THROMBOSIS RESEARCH, 2004, 114 (5-6) : 618 - 619
  • [5] APLASA study: Primary thrombosis prevention in asymptomatic antiphospholipid antibody (APL) positive patients with low-dose aspirin (ASA).
    Erkan, D
    Sammaritano, L
    Harrison, MJ
    Peterson, M
    Levy, R
    Yazici, Y
    Lockshin, MD
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S358 - S358
  • [6] Real world experience with antiphospholipid antibodies (APL): Comparison between antiphospholipid syndrome (Aps) and asymptomatic apl-positive patients.
    Derksen, W
    Erkan, D
    Kaplan, V
    Sammaritano, L
    Lockshin, MD
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S67 - S67
  • [7] SPECIFIC ANTIPHOSPHOLIPID ANTIBODIES (APL) ELUTED FROM PLACENTAE OF PREGNANT-WOMEN WITH APL-POSITIVE SERA
    KATANO, K
    AOKI, K
    OGASAWARA, M
    SASA, H
    HAYASHI, Y
    KAWAMURA, M
    YAGAMI, Y
    LUPUS, 1995, 4 (04) : 304 - 308
  • [8] Small but Clinically Insignificant Decreases in Antiphospholipid Antibody Titers Occur in aPL-Positive Patients during Pregnancy
    Yelnik, Cecile
    Porter, Flint
    Branch, Ware D.
    Buyon, Jill P.
    Guerra, Marta
    Laskin, Carl
    Lockshin, Michael
    Petri, Michelle
    Merrill, Joan T.
    Sammaritano, Lisa R.
    Stephenson, Mary D.
    Kim, Mimi Y.
    Salmon, Jane E.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [9] Cognitive dysfunction in antiphospholipid antibody (aPL)-negative systemic lupus erythematosus (SLE) versus aPL-positive non-SLE patients
    Kozora, E.
    Erkan, D.
    Zhang, L.
    Zimmerman, R.
    Ramon, G.
    Ulug, A. M.
    Lockshin, M. D.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (01) : 34 - 40
  • [10] APLASA study 2004 update: Primary thrombosis prevention in asymptomatic antiphospholipid antibody (APL) positive patients with low-dose aspirin (ASA)
    Erkan, D
    Sammaritano, L
    Levy, R
    Harrison, MJ
    Peterson, M
    Yazici, Y
    Lockshin, MD
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S640 - S641
12345